CAMBRIDGE, Mass.–(BUSINESS WIRE)–Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) disorders and chronic pain, today announced receipt of a Small Business Innovation Research (SBIR) grant…
CAMBRIDGE, Mass., June 18, 2025 /PRNewswire/ — Biobot Analytics, the leader in wastewater intelligence, today announced a new round of funding led by Valor Equity Partners. Alongside Valor, Biobot is also welcoming new investor Atreides Management, as well as participation from…
Signs on Eight Pharmaceutical Partners and Completes First Preclinical Study from Immune Organoid Platform with Centivax CAMBRIDGE, Mass.–(BUSINESS WIRE)–Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series…
─ $85 million in financing includes recent $45 million Series A extension with participation from founding investors RA Capital Management and Khosla Ventures and six new investors including biopharmaceutical company venture funds Chugai Venture Fund,…
According to filings with the U.S. Securities and Exchange Commission, Lytica Therapeutics is raising up to $6,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
Financing led by Venrock Healthcare Capital Partners with co-lead Forbion Growth, and participation from RTW Investments, Nextech Invest, and other new investors Current investors ARCH Venture Partners, Forbion Ventures, ND Capital, and others also participated…
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ — Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a $110 million Series E financing led by a private equity fund of Value…
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ — OpenEvidence, the fastest-growing platform for doctors in history, has closed a Series A with Sequoia Capital at a $1 billion valuation. This milestone marks OpenEvidence’s first institutional investment and brings the company’s…
Tandem Expands Its AI-Powered Pet Healthcare Platform with a 5000 sq ft Smart Health Hub February 24, 2025 10:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Tandem, a pet healthcare startup on a mission to deliver…
According to filings with the U.S. Securities and Exchange Commission, MacroCycle Technologies is raising up to $7,019,997.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…